Julie Winter

Julie Winter is Vice President of Business Development at Kyverna Therapeutics. Prior to Kyverna she was VP Business Development at PaxVax, Inc., where she led major corporate transactions, culminating in the sale of PaxVax to Emergent Biosolutions in 2018 for $270 million.

Overview Structured Data Issues Contributors

Is a

Person

Person attributes

Founder of

Occupation

Wellfound ID

Other attributes

Affiliated With

Kyverna Therapeutics

AngelList URL

angel.co/julie-winter-2

Related Organization

Kyverna Therapeutics

No article content yet.

Timeline

No Timeline data yet.

Current Employer

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more people like Julie Winter

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.